These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11343737)

  • 21. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
    Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE gene polymorphism and coronary restenosis.
    Bauters C; Amouyel P; Bertrand ME
    Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
    Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation.
    Canosi U; Angelica Merlini P; Bernardi F; Repetto A; Bramucci E; Ferrario M; Angoli L; Gnecchi M; Ferraresi P; Marchetti G; Tavazzi L; Ardissino D
    Thromb Haemost; 2004 Apr; 91(4):795-800. PubMed ID: 15045142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.
    Yamazaki T; Taniguchi I; Kurusu T; Shimazu Y; Hashizume Y; Takikawa K; Kuwata M; Onodera T; Yoshikawa M; Mochizuki S
    Circ J; 2004 Apr; 68(4):328-33. PubMed ID: 15056829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting.
    Okumura K; Kamiya H; Matsui H; Sone T; Kondo J; Tsuboi H; Mukawa H
    Atherosclerosis; 2001 Dec; 159(2):527-8. PubMed ID: 11730835
    [No Abstract]   [Full Text] [Related]  

  • 33. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
    Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
    Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients.
    Taniguchi I; Yamazaki T; Wagatsuma K; Kurusu T; Shimazu Y; Takikawa K; Yoshikawa M; Kageyama S; Mochizuki S
    Jpn Circ J; 2001 Oct; 65(10):897-900. PubMed ID: 11665795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
    Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
    Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
    Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
    Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.